News
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback